Henry Dombrowski

Henry Dombrowski has over 15 years of work experience, with a focus in the biopharmaceutical industry. Henry currently holds the position of Vice President, Controller at Day One Biopharmaceuticals, starting in August 2022. Prior to this, they worked at Alexion Pharmaceuticals, Inc., where they held various senior director roles, including Alexion Finance Integration Lead and Global Finance Business Services Lead. Henry also served as Director of Americas Controller & Record to Report Global Process Owner and Associate Director of the Financial Leadership Development Program. Before their time at Alexion Pharmaceuticals, Henry worked at PwC as a Senior Associate in Audit. Their tenure at PwC spanned from September 2007 to April 2013.

Henry Dombrowski completed their Bachelor of Science (BS) degree in Accounting at the University of Connecticut in an unknown year, but their education at the university ended in 2007. Henry then pursued a Master of Science (MS) degree in Accounting from the same university, completing it in 2009. In 2021, Henry began studying for a Master of Science (MS) degree in Finance at Northeastern University. There is no available information about their field of study for this degree. Additionally, Henry holds a CPA certification from the State of Connecticut, but the specific year of obtaining this certification is unknown.